These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35130792)

  • 1. Nanocurcumin formulation: a possible therapeutic agent for post COVID inflammatory syndrome.
    Kushwaha AD; Mishra KP; Singh M; Ganju L; Saraswat D
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):141-146. PubMed ID: 35130792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nanocurcumin and Pyrroloquinoline Quinone Formulation Prevents Hypobaric Hypoxia-Induced Skeletal Muscle Atrophy by Modulating NF-κB Signaling Pathway.
    Kushwaha AD; Saraswat D
    High Alt Med Biol; 2022 Sep; 23(3):249-263. PubMed ID: 35384739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocurcumin-pyrroloquinoline formulation prevents hypertrophy-induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions.
    Nehra S; Bhardwaj V; Bansal A; Chattopadhyay P; Saraswat D
    Exp Mol Med; 2017 Dec; 49(12):e404. PubMed ID: 29611541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis.
    Nehra S; Bhardwaj V; Ganju L; Saraswat D
    PLoS One; 2015; 10(9):e0139121. PubMed ID: 26406246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial therapy of exercise-preconditioning and nanocurcumin formulation supplementation improves cardiac adaptation under hypobaric hypoxia.
    Nehra S; Bhardwaj V; Bansal A; Saraswat D
    J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):443-453. PubMed ID: 28672774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Hypobaric Hypoxia Induces Right Ventricular Hypertrophy and Apoptosis in Rats: Therapeutic Potential of Nanocurcumin in Improving Adaptation.
    Nehra S; Bhardwaj V; Kar S; Saraswat D
    High Alt Med Biol; 2016 Dec; 17(4):342-352. PubMed ID: 27626325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hypobaric hypoxia on the fiber type transition of skeletal muscle: a synergistic therapy of exercise preconditioning with a nanocurcumin formulation.
    Kushwaha AD; Varshney R; Saraswat D
    J Physiol Biochem; 2023 Aug; 79(3):635-652. PubMed ID: 37147493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocurcumin accords protection against acute hypobaric hypoxia induced lung injury in rats.
    Nehra S; Bhardwaj V; Bansal A; Saraswat D
    J Physiol Biochem; 2016 Dec; 72(4):763-779. PubMed ID: 27534650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective.
    Al-Kuraishy HM; Al-Gareeb AI; Negm WA; Alexiou A; Batiha GE
    Inflammopharmacology; 2022 Oct; 30(5):1493-1501. PubMed ID: 35922738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.
    Abbaspour-Aghdam S; Hazrati A; Abdolmohammadi-Vahid S; Tahmasebi S; Mohseni J; Valizadeh H; Nadiri M; Mikaeili H; Sadeghi A; Yousefi M; Roshangar L; Nikzad B; Jadidi-Niaragh F; Kafil HS; Malekpour K; Ahmadi M
    Eur J Pharmacol; 2022 Oct; 933():175267. PubMed ID: 36122756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic.
    Oyagbemi AA; Ajibade TO; Aboua YG; Gbadamosi IT; Adedapo ADA; Aro AO; Adejumobi OA; Thamahane-Katengua E; Omobowale TO; Falayi OO; Oyagbemi TO; Ogunpolu BS; Hassan FO; Ogunmiluyi IO; Ola-Davies OE; Saba AB; Adedapo AA; Nkadimeng SM; McGaw LJ; Kayoka-Kabongo PN; Oguntibeju OO; Yakubu MA
    J Food Biochem; 2021 Feb; 45(2):e13604. PubMed ID: 33458853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Long Non-coding RNA HSD17B3-AS1 in Trauma for COVID-19.
    Javanmard AR; Esmaeili Gouvarchinghaleh H; Dorostkar R; Tat M
    Iran J Allergy Asthma Immunol; 2023 Sep; 22(4):345-353. PubMed ID: 37767677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets.
    Serebrovska ZO; Chong EY; Serebrovska TV; Tumanovska LV; Xi L
    Acta Pharmacol Sin; 2020 Dec; 41(12):1539-1546. PubMed ID: 33110240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.
    Lu LW; Gao Y; Quek SY; Foster M; Eason CT; Liu M; Wang M; Chen JH; Chen F
    Biomed Pharmacother; 2022 Oct; 154():113625. PubMed ID: 36058151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
    González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
    Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.